Cargando…
LKB1IP promotes pathological cardiac hypertrophy by targeting PTEN/Akt signalling pathway
Pathological cardiac hypertrophy represents a leading cause of morbidity and mortality worldwide. Liver kinase B1 interacting protein 1 (LKB1IP) was identified as the binding protein of tumour suppressor LKB1. However, the role of LKB1IP in the development of pathological cardiac hypertrophy has not...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933949/ https://www.ncbi.nlm.nih.gov/pubmed/33486894 http://dx.doi.org/10.1111/jcmm.16199 |